← Back to blog

Understanding FDA 483 Observations in CGT Manufacturing

CDMO Signal · 2026-05-23

An FDA Form 483 is issued at the conclusion of a facility inspection when investigators have observed conditions that may violate the FD&C Act.

Common 483 Categories in CGT

  • Equipment and Facility — Environmental monitoring failures, cleanroom issues
  • Production Controls — Deviations from SOPs, batch record deficiencies
  • Laboratory Controls — OOS investigations, stability testing gaps
  • Data Integrity — The most serious findings

Read our full scoring methodology

Search 190+ CDMOs by FDA, EMA & clinical trial data

Free. No signup. AI-powered.

Try CDMO Signal
Share: LinkedIn X